基本説明
The first book devoted to use of botulinum toxin (BoNT) in the genitourinary tract, a hot topic following FDA approval of onabotulinumtoxinA for treatment of urinary incontinence due to neurogenic detrusor overactivity.
Full Description
Bladder injection of onabotulinumtoxinA for the treatment of urinary incontinence due to neurogenic detrusor overactivity has recently been approved by regulatory agencies in several EU countries and by the FDA in the United States.



